Basics Xilio Therapeutics, Inc. Common Stock IPO Date: October 18, 2021 Sector: Healthcare Industry: Biotech Market Cap: $45.51M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 5.00% Avg Daily Range (30 D): $0.04 | 4.60% Avg Daily Range (90 D): $0.04 | 4.21% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): 1.58M Avg Daily Volume (90 D): 2.67M Trade Size Avg Trade Size (Sh.): 341 Avg Trade Size (Sh.) (30 D): 427 Avg Trade Size (Sh.) (90 D): 435 Institutional Trades Total Inst.Trades: 16 Avg Inst. Trade: $2.12M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $.53M Avg Inst. Trade Volume: .7M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.69M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 597.56K         News Jun 2, 2025 @ 10:11 AM Xilio Therapeutics Announces Proposed Public Offer... Source: Globe Newswire May 31, 2025 @ 12:00 PM Xilio Therapeutics Announces Updated Phase 2 Data ... Source: N/A Mar 11, 2025 @ 11:30 AM Xilio Therapeutics Announces Pipeline and Business... Source: N/A Feb 10, 2025 @ 3:00 PM RNA Based Therapeutic Market Size Expected to Reac... Source: Towards Healthcare Oct 30, 2024 @ 1:01 PM Xilio Therapeutics to Present Initial Phase 1C Dos... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.18 $-.18 $-1.09 Diluted EPS $-.18 $-.18 $-1.09 Revenue $ 2.93M $ 1.72M $ 6.34M Gross Profit $ $ $ Net Income / Loss $ -13.27M $ -13.09M $ -58.24M Operating Income / Loss $ -13.85M $ -13.63M $ -60.58M Cost of Revenue $ $ $ Net Cash Flow $ 33.79M $ -5.96M $ 10.78M PE Ratio